1800 202 8726
Follow-Up Scanning

Surveillance Scanning — by Cancer Type

The scans you need after treatment — and how often — depend on which cancer you had, how it was treated, and how long ago you finished. This reference table sets out general patterns for eight common cancer types, drawn from NCCN and ESMO guidelines.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Different cancers use different scans — Breast cancer follow-up relies on mammography; colorectal uses CT; prostate surveillance centres on PSA rather than imaging.
  • Frequency reduces over time — For most cancer types, scans are more intensive in years one and two, then space out if there is no sign of recurrence.
  • Some cancers use blood tests, not scans — Prostate surveillance centres on PSA; ovarian cancer uses CA-125 alongside imaging at each visit.
  • Schedules are clinician-directed — These are general patterns from guidelines. Your actual schedule is set by your oncologist based on your treatment and individual risk.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

The scan you need depends on your cancer type and when you finished treatment. Most solid tumours are followed with CT or MRI in the first two to five years, alongside regular clinical examination. Your oncologist sets the schedule using NCCN or ESMO guidelines for your specific diagnosis — there is no single answer across all cancers.

CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.

Why does the scan type change depending on the cancer?

Each cancer type tends to recur in particular places. Colorectal cancer most commonly recurs in the liver and lungs, so CT imaging of those areas is the surveillance focus. Breast cancer most commonly recurs in the breast tissue, so annual mammography is the standard — and CT is not recommended for asymptomatic patients by NCCN.

The scan that is most useful is the one most likely to detect recurrence early for your particular cancer. Ordering a scan not matched to the recurrence pattern adds cost and radiation exposure without improving detection.

Blood and hormone markers add another layer. CEA for colorectal cancer, CA-125 for ovarian cancer, and PSA for prostate cancer can signal a problem before it is visible on imaging — so they are checked at regular intervals alongside or instead of scans.

What scan does each cancer type typically use?

Cancer typeScan usedFirst 2 yearsYears 3–5Blood or other test
Breast (early stage)Annual mammogram — CT not routine for asymptomatic patients (NCCN)AnnuallyAnnuallyClinical exam throughout; no blood marker standard
ColorectalCT chest, abdomen and pelvisEvery 6–12 monthsAnnually to year 5CEA every 3–6 months; colonoscopy at year 1
Lung (NSCLC)CT chestEvery 6–12 monthsAnnuallyNone standard
CervicalCT or PET-CT for high-risk; pelvic exam for allEvery 3–6 monthsEvery 6–12 monthsPap smear as appropriate
Prostate (post-treatment)Bone scan or CT only if PSA rises or symptoms occurScan only if clinically indicatedScan only if clinically indicatedPSA every 3–6 months for 2 years, then 6-monthly
Hodgkin lymphomaCT limited after confirmed complete response (NCCN)Per treating oncologistAs clinically indicatedNone standard
Head and neckCT or MRIEvery 3–6 monthsEvery 6–12 monthsTSH if thyroid was in the radiation field
OvarianCT abdomen and pelvisEvery 3–6 monthsEvery 6–12 monthsCA-125 at each visit

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Common questions about your surveillance schedule

Why do scans become less frequent after the first two years?

Recurrence risk is highest in the first one to two years after treatment for most solid tumours. Surveillance is most intensive during that window because detecting a recurrence early — when it is small and localised — gives the most treatment options. As each year passes without a problem, the probability of a recurrence in the next year generally falls, so the interval between scans widens. This is a clinical judgement grounded in evidence, not a cost-saving measure. Your oncologist will tell you if there is a reason to maintain closer follow-up than the standard schedule.

What does 'as clinically indicated' mean in a surveillance plan?

It means there is no fixed scan date — the next scan is ordered when something prompts it, such as a symptom you report, a blood marker that rises, or an examination finding. Prostate cancer surveillance commonly works this way: PSA is checked at regular intervals, and imaging is ordered only if the result is concerning. It does not mean you are being watched less carefully. It means the blood test is more sensitive for early recurrence than a routine scan in that situation, so the scan is held back until it will genuinely add information.

Can I reduce how often I am scanned to lower cost and radiation exposure?

Discuss this with your oncologist rather than deciding alone. For some cancer types, guidelines already recommend the minimum number of scans that the evidence supports. For others — particularly colorectal cancer — the schedule reflects a genuine difference in early recurrence detection if visits are spaced further apart. Radiation from CT scans is real but the dose per scan is small, and your oncologist can put the cumulative exposure in context for your situation. Cost concerns are worth raising directly — your team can explain government scheme eligibility or discuss what is available to you.

Does a PET-CT replace a standard CT for routine surveillance?

Not for most cancer types. PET-CT is the standard for initial staging and treatment response assessment in several cancers, including lymphomas. For routine surveillance of solid tumours in remission, standard CT is what NCCN and ESMO guidance recommends. PET-CT is more expensive, involves a higher radiation dose, and has a higher false-positive rate in the surveillance setting — where the probability of finding active disease is lower. A false positive leads to further investigation that adds cost, radiation and anxiety. Your oncologist will advise if PET-CT is specifically indicated for your follow-up.

What should I do if I have missed a scheduled scan?

Contact your oncology team and reschedule as soon as you can. Missing one scan does not mean a recurrence has been missed — it means there is a gap in the monitoring record. The team will advise whether to continue with the original schedule, bring the next scan forward, or add an interim scan before returning to the usual pattern. Do not wait for the next scheduled appointment to mention it. Call and let them know, so the decision about how to proceed is made by your team rather than left to chance.

Did you know?

For most early-stage breast cancers, NCCN guidelines do not recommend routine CT, bone scan or PET-CT for surveillance in patients without symptoms. Annual mammography and clinical examination are the evidence-based standard.

Scans ordered without a matched clinical reason add radiation exposure and cost without improving outcomes — a finding that has shifted surveillance guidelines for several cancer types over the past decade.

Source: NCCN Clinical Practice Guidelines in Oncology — Breast Cancer

A whole-body PET-CT at CION is Rs 10,499 — among the lowest published prices in Hyderabad — with a free Rs 950 oncologist consultation to talk through your report. Indicative price, as of September 2026.

Explore 62 more Family Support, Myths, Follow-Up and Emergencies topics

All Family Support, Myths, Follow-Up and Emergencies →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Does every cancer type need a different scan for surveillance?

Yes, because each cancer type tends to recur in different places and at different rates. Breast cancer surveillance centres on mammography because local and regional recurrence in breast tissue is what imaging needs to detect. Colorectal cancer surveillance uses CT of the chest, abdomen and pelvis because the liver and lungs are the most common sites of spread. Using the same scan across all cancers would miss recurrences that the right scan would find — and would add unnecessary procedures where they add no value.

How long does surveillance scanning continue after treatment?

It varies by cancer type. For most solid tumours, the structured surveillance period recommended by NCCN and ESMO runs for five years, with scans becoming less frequent after the first two to three years. After five years, many patients move to annual clinical review without routine imaging — though mammography continues indefinitely for breast cancer. For some blood cancers and cancers with late recurrence patterns, surveillance may continue beyond five years. Ask your oncologist when your scheduled imaging is expected to end and what follows.

What is the difference between a surveillance scan and a diagnostic scan?

A surveillance scan is done on a schedule in a patient with no symptoms and no signs of recurrence — it is looking for a problem before it causes symptoms. A diagnostic scan is ordered because something is wrong: a symptom, an abnormal blood test, or a clinical finding. The two are interpreted differently. A surveillance scan in a patient who feels well has a low probability of finding active disease. A diagnostic scan in a patient with symptoms has a much higher one, and the radiologist reports it with that context in mind.

Can I request more frequent scans if I am anxious about recurrence?

You can and should raise your anxiety with your oncologist — that is an important part of the conversation. Whether more frequent scanning helps is a different question. Guideline-recommended intervals reflect the point at which scanning has been shown to be most useful, and scanning beyond that does not generally improve outcomes. More frequent scans can increase false-positive findings, which lead to further procedures that themselves cause anxiety. If worry about recurrence is significantly affecting your daily life, your oncologist can refer you to psychological support alongside your surveillance plan.

Is PET-CT better than CT for routine follow-up after treatment?

Not for most cancer types. PET-CT is established for initial staging and treatment response assessment — particularly in lymphomas. For routine surveillance of patients in remission, NCCN and ESMO guidance for most solid tumours recommends standard CT. PET-CT is more sensitive but also has a higher rate of false-positive results in a population where most patients do not have active disease. A false positive means further investigation, which adds cost, radiation and anxiety without benefit. Your oncologist will recommend PET-CT when your situation specifically calls for it.

What happens if a follow-up scan finds something?

The next step depends entirely on what is found. A small indeterminate finding — a slightly enlarged lymph node, a shadow in the lung — will usually mean a repeat scan in a few weeks to see whether it changes. A finding that looks clearly abnormal may lead to a biopsy to confirm whether it is recurrence. Your oncologist will explain the finding and the plan before any next steps are taken. The goal of surveillance is to find a recurrence small enough that treatment options remain broad — which is why regular follow-up matters even when you feel well.

Call now Book free consultation